Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vanderbilt-Ingram Cancer Center
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Subjects must have histologically proven breast cancer
Subjects are being considered for preoperative chemotherapy
Subjects must be ≥ 18 years old. Sensor Sub-Study Only
Palpable subcutaneous or known disease with one surface \<1cm below surface of skin.
A subset of patients who have a mass located on any surface of the breast that is accessible for Lucerno sensor placement will have additional testing.
You may not be if
Children will be excluded from this study.
Pregnant women and women who are breast feeding will be excluded from this study. (The Vanderbilt University Medical Center radiology "PET Procedure Screening Form" will be used to identify and exclude subjects who are pregnant or breastfeeding. A urine pregnancy test/or serum beta HCG will also be performed for women of child bearing potential).
Patients who are acutely ill who are deemed by their treating physician as not suitable candidates for this study.
Intraluminal lesions will be excluded from the sensor sub-study.
Non biopsy proven malignancy will be excluded from this study.
Palpable subcutaneous or known disease with one surface \>1cm below surface of skin will be excluded from the sensor sub-study.
Draining or exposed malignant tumor will be excluded from the sensor sub-study.
Clareo Health | PET/CT Evaluation of Treatment Response in Breast Cancer
